Institution Decisions (2) In Mylan Pharmaceuticals, Inc. v. Gilead Sciences, Inc., IPR2014-00886, Paper 15 (December 17, 2014), the Board declined to institute inter partes review of  claims 1–7, 9–14, and 16–18 of U.S. Patent No. 5,935,946. In Renesas Electronics Corporation v. ZOND, INC., IPR2014-01066, Paper … Continue reading December 17, 2014